NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 02 04:00PM ET
7.47
Dollar change
+0.14
Percentage change
1.84
%
Index- P/E- EPS (ttm)-4.68 Insider Own70.00% Shs Outstand2.79M Perf Week-0.33%
Market Cap20.80M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.84M Perf Month3.11%
Enterprise Value5.08M PEG- EPS next Q- Inst Own19.14% Short Float3.13% Perf Quarter51.94%
Income-13.04M P/S1.72 EPS this Y- Inst Trans1.27% Short Ratio0.76 Perf Half Y-33.35%
Sales12.10M P/B1.03 EPS next Y- ROA-38.95% Short Interest0.03M Perf YTD-19.74%
Book/sh7.24 P/C1.23 EPS next 5Y- ROE-49.39% 52W High16.50 -54.76% Perf Year-16.12%
Cash/sh6.07 P/FCF- EPS past 3/5Y- 21.32% ROIC-62.36% 52W Low3.34 123.50% Perf 3Y-83.50%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-28.28% -12.81% Gross Margin- Volatility2.47% 4.55% Perf 5Y-92.06%
Dividend TTM- EV/Sales0.42 EPS Y/Y TTM43.06% Oper. Margin-118.75% ATR (14)0.39 Perf 10Y-
Dividend Ex-Date- Quick Ratio5.12 Sales Y/Y TTM603.66% Profit Margin-107.77% RSI (14)54.46 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio5.12 EPS Q/Q-38.84% SMA203.15% Beta1.17 Target Price40.00
Payout- Debt/Eq0.06 Sales Q/Q121.24% SMA501.36% Rel Volume0.02 Prev Close7.33
Employees34 LT Debt/Eq0.04 EarningsMay 23 BMO SMA2009.84% Avg Volume34.41K Price7.47
IPOFeb 01, 2018 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume527 Change1.84%
Date Action Analyst Rating Change Price Target Change
Aug-19-24Downgrade Raymond James Strong Buy → Outperform $6 → $4
Oct-21-22Resumed Jefferies Hold $5.50
Dec-31-19Reiterated JMP Securities Mkt Outperform $20 → $33
Dec-31-19Reiterated H.C. Wainwright Buy $23 → $26
May-23-25 07:15AM
May-01-25 07:00AM
Apr-17-25 08:40AM
Nov-20-24 12:00PM
07:00AM
08:10AM Loading…
Nov-15-24 08:10AM
07:00AM
Sep-17-24 09:55AM
Aug-27-24 12:00PM
Aug-17-24 11:27AM
Aug-16-24 08:10AM
07:00AM
Jul-25-24 07:00AM
Jul-15-24 07:00AM
May-28-24 07:00AM
01:53PM Loading…
May-20-24 01:53PM
08:10AM
07:00AM
May-16-24 06:00AM
Apr-01-24 07:00AM
Mar-13-24 07:00AM
Nov-30-23 07:00AM
Nov-28-23 08:06AM
Nov-09-23 07:00AM
Oct-31-23 06:43AM
Oct-30-23 10:05AM
Aug-30-23 08:00AM
Aug-10-23 08:15AM
07:00AM
Jul-21-23 06:04AM
07:30AM Loading…
Jun-06-23 07:30AM
Jun-02-23 06:09AM
May-12-23 08:25AM
07:00AM
Apr-22-23 08:19AM
Mar-22-23 05:43AM
Mar-20-23 07:00AM
Mar-15-23 11:44AM
Mar-12-23 08:23AM
Mar-10-23 08:15AM
07:00AM
Feb-27-23 06:02AM
Feb-23-23 02:32PM
Jan-27-23 07:29AM
07:00AM
Dec-08-22 06:16AM
Dec-07-22 10:52AM
Nov-10-22 04:00AM
Nov-03-22 03:03PM
Oct-03-22 08:00AM
Sep-19-22 01:00PM
Sep-12-22 04:30AM
Sep-09-22 12:13PM
Aug-04-22 06:00AM
Jun-01-22 08:00AM
May-27-22 11:45AM
May-17-22 07:00AM
May-13-22 07:00AM
Apr-25-22 07:00AM
Apr-14-22 08:30AM
Apr-12-22 11:26AM
Mar-30-22 07:00AM
Mar-25-22 11:00AM
Dec-22-21 04:05PM
Dec-21-21 07:00AM
Nov-30-21 08:27AM
Nov-11-21 07:00AM
Nov-09-21 07:05AM
Nov-04-21 07:30AM
Oct-01-21 12:14PM
Sep-22-21 07:30AM
Sep-09-21 08:30AM
Aug-17-21 01:30PM
Aug-04-21 07:05AM
Jul-27-21 10:26AM
09:15AM
Jul-20-21 07:05AM
Jun-28-21 05:10AM
05:00AM
May-27-21 07:00AM
May-18-21 09:27AM
May-13-21 07:05AM
Apr-28-21 08:41PM
Apr-27-21 02:20PM
10:02AM
Mar-19-21 06:56AM
Mar-10-21 10:29AM
Mar-04-21 07:05AM
Feb-24-21 07:05AM
Jan-18-21 07:49AM
Jan-11-21 07:05AM
Dec-07-20 07:05AM
Dec-01-20 08:33AM
Nov-18-20 12:08AM
Nov-16-20 01:25AM
Nov-12-20 08:21AM
07:05AM
Nov-09-20 07:05AM
Nov-04-20 04:05PM
Sep-28-20 02:34PM
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.